Skip to main content
Premium Trial:

Request an Annual Quote

Belgium s AlgoNomics Raises 1.8M Euros in Private Placement

NEW YORK, June 5 – Structural bioinformatics company AlgoNomics of Ghent, Belgium, said Tuesday it had raised 1.8 million euros ($1.5 million) in a second round of private financing.

The company will use the cash injection to accelerate the research, development, and commercialization of its products.

The investors who participated in the financing round include the KU Leuven Gemma-Frisius Fund, Trustcapital Technology, Fortis Private Equity, and Investco.

The company has developed the Dead-End Elimination algorithm and provides DEE-based modeling and protein engineering technology.

Algonomics integrates generic bioinformatics tools with expert biocomputing methods and then offers services, including protein structure analysis, functional characterization, mutagenesis, and protein design and fold recognition, to biotech and pharma companies via the Internet.

The company has raised a total of over 3 million euros to date.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.